Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis
Pia Villa, Pietro Ghezzi(Brighton and Sussex Medical School), Michael Brines(Northwell Health), Barbara Viviani(University of Milano-Bicocca), Alfredo Cagnotto(Mario Negri Institute for Pharmacological Research), Tiziana Mennini(Mario Negri Institute for Pharmacological Research), Teresa Laragione(Mario Negri Institute for Pharmacological Research), Thomas R. Coleman(University of Messina), Paolo Bigini(Mario Negri Institute for Pharmacological Research), Marina Marinovich(University of Milan), Davide Agnello(Mario Negri Institute for Pharmacological Research), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 535
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906
Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases
|Journal of Neuroscience|2003|843